AstraZeneca’s COVID-19 vaccine may receive EUA from India soon
By Nikita Chaurasia  Date: 2020-12-24

AstraZeneca’s COVID-19 vaccine may receive EUA from India soon

Reportedly, India intends to grant emergency use authorization (EUA) to Oxford/AstraZeneca’s coronavirus vaccine by next week, following submission of some additional data to the concerned authorities by a few local manufacturers. India could be the first country to approve AstraZeneca’s vaccine as the British drugmaker continues the process of examining data from its clinical trials.

Being the biggest vaccine-making country worldwide, India intends to begin immunizing the population starting next month and is in talks of approving EUA applications for Coronavirus vaccines made by local company Bharat Biotech as well as the American pharmaceutical giant Pfizer Inc., claimed trusted sources.

In this context, experts cite that the AstraZeneca-Oxford COVID-19 shot is essential in countries with lower-income and hot climatic conditions as it is inexpensive, easy to transport, and can be stored at normal fridge temperatures for long periods.

The Central Drugs Standard Control Organization (CDSCO) of India had initially assessed the three applications on 9th December and requested more information from all the pharmaceutical firms, including Serum Institute of India (SII), the company which is reportedly producing the AstraZeneca vaccines.

Although Serum Institute has provided all the data required, the authorities are reportedly awaiting information from Pfizer, and some additional information from Bharat Biotech, sources confirmed.

According to the data released by AstraZeneca of their late-stage trials in Brazil and in the U.K., the vaccine showed 62% efficacy among trial participants who were given two dosages each, and 90% efficacy for a smaller group of people given first a half, and then a full dosage, which evidently forms the base of the anticipated approval.

If sources are to be believed, only two full-dose regimens of the COVID-19 vaccine are being considered by the Indian regulator despite its lower success rate.

India is yet to sign a vaccine supply agreement with any pharmaceutical company; however, Serum Institute has reportedly stockpiled over 50 million doses of the AstraZeneca vaccines and intends to make a total of 400 million doses by July 2021, cited sources knowledgeable with the matter.

Source Credits –

https://in.reuters.com/article/uk-health-coronavirus-india-vaccine-excl/exclusive-india-likely-to-approve-astrazeneca-vaccine-by-next-week-sources-idINKBN28W27I

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

ClaimBuddy secures undisclosed sum in Titan Capital-led funding round
ClaimBuddy secures undisclosed sum in Titan Capital-led funding round
By Nikita Chaurasia

Indian insurance technology startup ClaimBuddy has reportedly raised an undisclosed amount in a seed funding round which was led by Titan Capital and involved participation from other marquee investor groups including First Cheque as well as LV Angel...

Mercedes-Benz unveils the EQA SUV in a bid to outdo Tesla, Volkswagen
Mercedes-Benz unveils the EQA SUV in a bid to outdo Tesla, Volkswagen
By Nikita Chaurasia

Daimler AG owned German automotive giant, Mercedes-Benz, has reportedly introduced the EQA, a new electric compact SUV to compete with market leader Tesla, Inc. as well as to meet its carbon targets in China and Europe. The Mercedes-Benz EQA, one of...

New York planning on direct purchase of Pfizer’s COVID-19 vaccines
New York planning on direct purchase of Pfizer’s COVID-19 vaccines
By Nikita Chaurasia

In recent developments, Governor of New York, Andrew Cuomo has reportedly issued a letter to the CEO of American drug maker Pfizer Inc., Albert Bourla, requesting for direct purchase of COVID-19 vaccine doses. Although the company is not bound to any...

Mayo Clinic Laboratories forms alliance with American Hospital Dubai
Mayo Clinic Laboratories forms alliance with American Hospital Dubai
By Nikita Chaurasia

In recent developments, Minnesota-based Mayo Clinic Laboratories and American Hospital Dubai are reportedly planning on entering a strategic alliance which is aimed at enhancing advanced laboratory diagnostic services in Dubai. Under the terms of th...

LTI, IBM extend global partnership to spearhead digital transformation
LTI, IBM extend global partnership to spearhead digital transformation
By Nikita Chaurasia

The New York-headquartered IBM Corp., with its global partner Larsen Toubro Infotech, an Indian global IT solutions & services company, are planning to extend their multi-year partnership, in a bid to enable companies to revolutionize the busines...